Showing results (51-60 of 91) with videos related to
Sort By:
Pageof 10
Clinical Genitourinary Cancer|June 17, 2026
Assessment of Tumor Microenvironment Inflammatory Biomarkers in Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint InhibitorsLars Drüke, Jessica Schmitz, Manuel M Vicente, et al.Medical Oncology (Northwood, London, England)|May 12, 2016
Do programmed death 1 (PD-1) and its ligand (PD-L1) play a role in patients with non-clear cell renal cell carcinoma?Mahmoud Abbas, Sandra Steffens, Maria Bellut, et al.Anticancer Research|July 29, 2026
Radiotherapy for Soft-tissue Sarcoma of the Extremities: A 10-Year Analysis of Treatment Outcomes and Toxicity at a Large Sarcoma CentreMara Both Vazquez, Mathias Sonnhoff, Roland Merten, et al.Oncology Research and Treatment|April 7, 2025
Quality of Life of Cancer Patients in Routine Clinical Care Using the Example of Checkpoint Inhibition Therapy: A Delphi ConsensusPhilipp Ivanyi, Bernd Alt-Epping, Lars Bullinger, et al.International Journal of Clinical Oncology|July 28, 2021
Impact of sarcopenia in advanced and metastatic soft tissue sarcomaDennis Strassmann, Bennet Hensen, Viktor Grünwald, et al.Future Oncology (London, England)|September 23, 2020
Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinomaPeter J Goebell, Philipp Ivanyi, Jens Bedke, et al.European Urology Focus|December 26, 2021
Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma after Prior Therapy: Interim Results from the Noninterventional NORA StudyMarc-Oliver Grimm, Viktor Grünwald, Harald Müller-Huesmann, et al.Frontiers in Oncology|June 13, 2020
Checkpoint Inhibition for Metastatic Urothelial Carcinoma After Chemotherapy-Real-World Clinical Impressions and Comparative Review of the LiteratureChristian Fuhrmann, Julian P Struck, Philipp Ivanyi, et al.Cancers|September 14, 2024
Cabozantinib Plus Nivolumab in Adult Patients with Advanced or Metastatic Renal Cell Carcinoma: A Retrospective, Non-Interventional Study in a Real-World Cohort/GUARDIANS ProjectThomas Hilser, Christopher Darr, Günter Niegisch, et al.Liver International : Official Journal of the International Association for the Study of the Liver|January 22, 2019
Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinomaLena Schulte, Bernhard Scheiner, Torsten Voigtländer, et al.Pageof 10